4.640USD-0.22%Mkt Cap: 599.22M $P/E: —1d ago
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lig…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap599.22M $
Enterprise Value364.48M $
Revenue (TTM)204.17M $
Gross Profit104.46M $
Net Income (TTM)-66.54M $
Revenue/Share1.597 USD
Last Price4.640 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees678
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)23.20
PEG—
EV/EBITDA-10.04
EV/Revenue1.79
P/S2.93
P/B1.83
EPS (TTM)-0.58
EPS (Forward)0.20
52W Range
3.09050% of range6.180
52W High6.180 USD
52W Low3.090 USD
Profitability
Gross Margin51.84%
Oper. Margin-41.83%
EBITDA Margin-17.78%
Profit Margin-33.02%
ROE-19.47%
ROA-14.42%
Growth
Revenue Growth6.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.69M $
CapEx (TTM)4.19M $
FCF Margin3.14%
FCF Yield1.07%
Net Debt-234.74M $
Net Debt/EBITDA6.47
Balance Sheet
Debt/Equity0.07
Current Ratio4.69
Quick Ratio3.94
Book Value/Sh2.537 USD
Cash/Share2.031 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.688 USD
Upside (mean)+22.6%
Target Range4.750 USD – 7.500 USD
$4.750+22.6% to mean$7.500
# Analysts4
Ownership
Shares Out.129.14M
Float96.58M
Insiders8.42%
Institutions67.59%
Short Interest
Short Ratio1.5d
Short % Float3.44%
Short % Out.2.72%
Shares Short3.51M
Short (prev mo.)7.30M
Technical
SMA 504.203 (+10.4%)
SMA 2004.529 (+2.5%)
Beta1.17
S&P 52W Chg20.25%
Avg Vol (30d)1.73M
Avg Vol (10d)935.38K
Technical Indicators
RSI (14)60.7
MACD0.1352
MACD Signal0.1159
MACD Hist.+0.0192
BB Upper4.950 USD
BB Middle4.388 USD
BB Lower3.825 USD
BB Width25.66%
ATR (14)0.2249 USD
Vol Ratio (20d)0.43x